227 related articles for article (PubMed ID: 2981130)
1. Increased binding of fibrinogen to platelets in diabetes: the role of prostaglandins and thromboxane.
DiMinno G; Silver MJ; Cerbone AM; Riccardi G; Rivellese A; Mancini M; Thiagarajan P
Blood; 1985 Jan; 65(1):156-62. PubMed ID: 2981130
[TBL] [Abstract][Full Text] [Related]
2. The binding of fibrinogen to platelets in diabetes mellitus.
di Minno G; Cerbone AM; Iride C; Mancini M
Wien Klin Wochenschr; 1986 Apr; 98(7):217-21. PubMed ID: 3010580
[TBL] [Abstract][Full Text] [Related]
3. Exposure of platelet fibrinogen-binding sites by collagen, arachidonic acid, and ADP: inhibition by a monoclonal antibody to the glycoprotein IIb-IIIa complex.
Di Minno G; Thiagarajan P; Perussia B; Martinez J; Shapiro S; Trinchieri G; Murphy S
Blood; 1983 Jan; 61(1):140-8. PubMed ID: 6216929
[TBL] [Abstract][Full Text] [Related]
4. Platelet dysfunction in uremia. II. Correction by arachidonic acid of the impaired exposure of fibrinogen receptors by adenosine diphosphate or collagen.
Di Minno G; Cerbone A; Usberti M; Cianciaruso B; Cortese A; Farace MJ; Martinez J; Murphy S
J Lab Clin Med; 1986 Sep; 108(3):246-52. PubMed ID: 3018111
[TBL] [Abstract][Full Text] [Related]
5. Identification of a new congenital defect of platelet function characterized by severe impairment of platelet responses to adenosine diphosphate.
Cattaneo M; Lecchi A; Randi AM; McGregor JL; Mannucci PM
Blood; 1992 Dec; 80(11):2787-96. PubMed ID: 1333302
[TBL] [Abstract][Full Text] [Related]
6. Thromboxane A2 causes feedback amplification involving extensive thromboxane A2 formation on close contact of human platelets in media with a low concentration of ionized calcium.
Packham MA; Kinlough-Rathbone RL; Mustard JF
Blood; 1987 Sep; 70(3):647-51. PubMed ID: 3620698
[TBL] [Abstract][Full Text] [Related]
7. Halysin, an antiplatelet Arg-Gly-Asp-containing snake venom peptide, as fibrinogen receptor antagonist.
Huang TF; Liu CZ; Ouyang CH; Teng CM
Biochem Pharmacol; 1991 Aug; 42(6):1209-19. PubMed ID: 1888330
[TBL] [Abstract][Full Text] [Related]
8. 13-Azaprostanoic acid: a specific antagonist of the human blood platelet thromboxane/endoperoxide receptor.
Le Breton GC; Venton DL; Enke SE; Halushka PV
Proc Natl Acad Sci U S A; 1979 Aug; 76(8):4097-101. PubMed ID: 291066
[TBL] [Abstract][Full Text] [Related]
9. Platelet fibrinogen binding in diabetes mellitus. Differences between binding to platelets from nonretinopathic and retinopathic diabetic patients.
DiMinno G; Silver MJ; Cerbone AM; Riccardi G; Rivellese A; Mancini M
Diabetes; 1986 Feb; 35(2):182-5. PubMed ID: 3943666
[TBL] [Abstract][Full Text] [Related]
10. A role for prostaglandins and thromboxanes in the exposure of platelet fibrinogen receptors.
Bennett JS; Vilaire G; Burch JW
J Clin Invest; 1981 Oct; 68(4):981-7. PubMed ID: 6270196
[TBL] [Abstract][Full Text] [Related]
11. The role of ADP secretion and thromboxane synthesis in factor VIII binding to platelets.
Di Minno G; Shapiro SS; Catalano PM; De Marco L; Murphy S
Blood; 1983 Jul; 62(1):186-90. PubMed ID: 6407547
[TBL] [Abstract][Full Text] [Related]
12. Exposure of platelet fibrinogen receptors by a monoclonal antibody to CD9 antigen.
Hato T; Ikeda K; Yasukawa M; Watanabe A; Kobayashi Y
Blood; 1988 Jul; 72(1):224-9. PubMed ID: 2455569
[TBL] [Abstract][Full Text] [Related]
13. Platelet aggregation and exposure of fibrinogen receptors by prostaglandin endoperoxide analogues.
Morinelli TA; Niewiarowski S; Kornecki E; Figures WR; Wachtfogel Y; Colman RW
Blood; 1983 Jan; 61(1):41-9. PubMed ID: 6293626
[No Abstract] [Full Text] [Related]
14. Antiaggregatory activity of 8-epi-prostaglandin F2 alpha and other F-series prostanoids and their binding to thromboxane A2/prostaglandin H2 receptors in human platelets.
Yin K; Halushka PV; Yan YT; Wong PY
J Pharmacol Exp Ther; 1994 Sep; 270(3):1192-6. PubMed ID: 7932171
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of ADP-induced platelet activation by 7-chloro-4-nitrobenz-2-oxa-1,3-diazole: covalent modification of aggregin, a putative ADP receptor.
Puri RN; Colman RW
J Cell Biochem; 1996 Apr; 61(1):97-108. PubMed ID: 8726359
[TBL] [Abstract][Full Text] [Related]
16. Investigation on a selective non-prostanoic thromboxane antagonist, BM 13.177, in human platelets.
Patscheke H; Stegmeier K
Thromb Res; 1984 Feb; 33(3):277-88. PubMed ID: 6424261
[TBL] [Abstract][Full Text] [Related]
17. Increased platelet thromboxane receptor sensitivity in diabetic patients with proliferative retinopathy.
Collier A; Tymkewycz P; Armstrong R; Young RJ; Jones RL; Clarke BF
Diabetologia; 1986 Aug; 29(8):471-4. PubMed ID: 3019811
[TBL] [Abstract][Full Text] [Related]
18. Exposure of fibrinogen receptors on fresh and stored platelets by ADP and epinephrine as single agents and as a pair.
Di Minno G; Capitanio AM; Thiagarajan P; Martinez J; Murphy S
Blood; 1983 Jun; 61(6):1054-9. PubMed ID: 6301579
[TBL] [Abstract][Full Text] [Related]
19. Differential ability of agonists to express distinct pools of fibrinogen (GpIIb/IIIa) receptors which can mediate the aggregation of human platelets.
Watts IS; Keery RJ; Lumley P
Thromb Haemost; 1989 Nov; 62(3):955-61. PubMed ID: 2512682
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of collagen-induced platelet activation by 5'-p-fluorosulfonylbenzoyl adenosine: evidence for an adenosine diphosphate requirement and synergistic influence of prostaglandin endoperoxides.
Colman RW; Figures WR; Scearce LM; Strimpler AM; Zhou FX; Rao AK
Blood; 1986 Aug; 68(2):565-70. PubMed ID: 3730618
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
